See what questions
a doctor would ask.
Pancreatic cancer is diagnosed in over 29,000 people annually in the US. It responds well to treatment if diagnosed early but mostly it is diagnosed in the later stages and thus the five year survival rate after diagnosis is usually only 1-4%. Current therapy for metastatic patients involves the use of gemcitabine. The University of Southern California is about to conduct a trial to evaluate the effectiveness of the new drug BAY 43-9006 when used alone and in conjunction with gemcitabine. 90 subjects with metastatic pancreatic cancer will be involved.
Source: summary of medical news story as reported by ajc - Health Day News
About: New pancreatic cancer drug trial provides hope for improved survival rates
Date: 29 January 2005
Source: ajc - Health Day News
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City